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Parkin is a cytosolic E3 ubiquitin ligase that is recruited to the mitochondria during 
cellular stress and has been suggested to be involved in a variety of biological processes such as 
mitophagy.  The recruitment of Parkin (PARK2) to the mitochondria is dependent upon the 
kinase activity and the accumulation of PINK1 on damaged mitochondria.  Mutations in either 
PINK1 or Parkin genes disrupt this protective pathway and lead to the accumulation of damaged 
mitochondria.  From a clinical standpoint, mutations in the PARK2 gene have been associated 
with the progression and onset of autosomal recessive juvenile parkinsonism.  Without the 
presence of a quality control system such as that of the PINK1/Parkin pathway, the accumulation 
of damaged mitochondria could lead to increased levels of oxidative stress, a decrease in ATP, 
and the progression towards cellular death.  However, many of the details regarding the 
mechanism of Parkin-mediated ubiquitination and its involvement in mitophagy are not fully 
established. 
The intent of this thesis is to further explore the function of Parkin by utilizing the yeast-
two hybrid system to identify novel Parkin interactors/substrates.  A HeLa (cervical cell 
carcinoma) cDNA library was screened using Parkin124-465 as the “bait” protein.  From this 
screening, six positive Parkin interactors were isolated and characterized.  Using this approach it 
is possible to gain a better understanding of the function of Parkin in regulating cellular 
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CHAPTER ONE: INTRODUCTION 
Clinical Significance 
Parkinson’s disease (PD) is considered to be the second most common neurodegenerative 
disorder and is characterized by four primary clinical symptoms: tremor, bradykinesia, rigidity, 
and postural instability [1].  Reduced dopamine neurotransmission due to the damage of 
dopaminergic neurons in the substantia nigra and the presence of Lewy body inclusions in nerve 
cells are pathological hallmarks of this incurable disease; however, the molecular mechanism of 
how these neurons become impaired is unclear [1].  While the majority of diagnosed PD cases 
are classified as sporadic and idiopathic, genetic studies of rare familial forms of PD have 
provided information about the significance of protein degradation pathways and mitochondrial 
dysfunction in the development of PD [1, 2].  Mutations in specific genes encoding for alpha-
synuclein and leucine-rich-repeat kinase 2 (LRRK2) have been connected to autosomal dominant 
forms of PD, while mutations in PTEN induced putative kinase 1 (PINK1) and Parkin genes 
have been associated with autosomal recessive forms of PD [1-3]. 
Aggregation of damaged mitochondria has been implicated in a variety of age-related 
disorders including PD and Alzheimer’s disease [1].  Damaged mitochondria are selectively 
removed by the process of mitophagy, in order to prevent the activation of cellular death 
(apoptosis) [4, 5].  Studies have revealed that a physical interaction between PINK1 and Parkin 
serves as a mitochondrial quality control system that promotes the selective degradation of 
defective mitochondria in mammalian cells [3, 6].  PINK1 encodes a serine/threonine kinase that 
contains a mitochondrial targeting sequence that allows for its localization to the mitochondria 
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[1, 3, 6].  In healthy mitochondrion, PINK1 is imported into the inner mitochondrial membrane 
where it is rapidly cleaved and degraded by various proteases [3, 4].  The stabilization and build-
up of PINK1 on the outer mitochondrial membrane is considered as a mechanism for detecting 
mitochondrial dysfunction [4, 5].   
Parkin is a cytosolic E3 ubiquitin ligase that translocates to the mitochondria during 
cellular stress and is speculated to be involved in a variety of biological processes, including 
mitophagy, cell survival pathways, and vesicle trafficking [6, 7].  The recruitment of Parkin to 
the mitochondria is dependent upon the kinase activity and the accumulation of PINK1 on 
damaged mitochondria [3, 4, 6].  Upon translocation to the mitochondria, the ubiquitin activity of 
Parkin increases leading to activation of mitophagy [7].  Mutations in either PINK1 or Parkin 
genes disrupt this protective pathway and lead to accumulation of damaged mitochondria [1, 4-
6].  In relation to PD, neurons in the substantia nigra region of the brain are particularly 
vulnerable to the effects of mitochondrial dysfunction [4].  Without the presence of a quality 
control system such as that of the PINK1/Parkin pathway, the accumulation of damaged 
mitochondria could lead to increased levels of oxidative stress, a decrease in ATP, and the 
progression towards cellular death [6].  However, many of the details regarding the mechanism 
of Parkin-mediated ubiquitination and its involvement in mitophagy are not fully established [7, 
8].  This project will utilize a yeast-two hybrid system to identify novel E2 conjugating enzymes 
and other potential proteins that interact with Parkin and define the mechanism of its normal 
function. 
The presence of numerous mutations and rearrangements in the PARK2 gene has been 
linked as the cause to early onset form of PD known as autosomal recessive juvenile 
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parkinsonism (AR-JP) [1, 2].  It has been suggested that individuals with mutations in the Parkin 
gene generally display symptoms in their early thirties, though the age of onset can vary widely 
[9].  Furthermore, this implies that because there is an earlier onset of Parkinson’s disease in 
individuals with Parkin mutations, patients over the age of thirty can attribute the onset of the 
disease to causes other than Parkin mutations [9].  In regards to the symptoms experienced by 
those diagnosed with AR-JP, they are more likely to experience dystonia and hyperreflexia, but 
in comparison to those with idiopathic Parkinson’s disease, such individuals tend to have a better 
response to levodopa but have a higher risk of experiencing dyskinesia during treatment [9].  As 
for the specific location of where the mutations occur within the Parkin gene, the use of PCR-
based techniques has proposed that the exon deletions, exon multiplications, truncating 
mutations, and missense mutations are predominately clustered within the RING-IBR-RING 
finger motif; however, the effects of the various mutations on the Parkin’s normal have not been 





Analyzing the structural components of Parkin can reveal new information regarding its 
potential function and activation.  The PARK2 gene encodes a protein, referred to as Parkin, 
consisting of 465 amino acids and contains an N-terminal ubiquitin-like (Ubl) domain and a C-
terminal RING2 (Really Interesting New Gene) domain [2, 3, 7, 10].  In between the N-terminus 
and the C-terminus lie two additional RING finger regions– RING0 and RING1 – and an 
additional in-between RING (IBR) finger that separates RING1 and RING2 (Figure 2) [2].  The 
RING-type zinc finger domain is characterized by a specific sequence of cysteines and histidines 
folded around two zinc cations, and this configuration provides stability and plays a key role in 
mediating protein-protein interactions [10].   
 The surface of the Ubl domain appears to be bound to the RING1 region via hydrophobic 
interaction and has the capability of binding to ubiquitin-interacting motifs and SH3 domains 
upon dissociation from RING1 [10].  Compared to other proteins containing RING finger 
regions, the RING0 domain is an atypical structure that is unique to Parkin [10].  Specifically, it 
is involved in coordinating two zinc atoms at each end of the domain with a hairpin structure 
[10].  The RING1 domain appears to be the only domain that resembles the common 
Cys3HisCys4 sequence and zinc coordination pattern (“cross-brace” motif) found in other RING 
fingers [10].  Furthermore, studies have revealed that this specific domain contains an E2 binding 
region, thus highlighting its involvement in Parkin’s E3 ubiquitin ligase activity [8, 10].  The 
IBR region participates in maintaining conformational flexibility, and it has been demonstrated 
that the missense mutation Gly328Glu located in the hinge region between RING1 and IBR can 
affect Parkin’s positioning and stability [10].  The RING2 domain displays a similar sequential 
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topology to that of the IBR region and contains two zinc-coordinating residues that interact with 
a hydrophobic groove in RING0 [10].  Each domain within the structure of Parkin has a specific 
function, thus mutations occurring within these regions can result in a variety of effects that can 




Overview of Ubiquitination Process 
 Similar to the function of other RING finger proteins, Parkin acts as an E3 ubiquitin 
ligase in the ubiquitin-proteasome system (UPS) [2, 8, 10].  UPS is identified as the principle 
mechanism for proteolysis in eukaryotic cells; it is an ATP-dependent process that involves the 
conjugation of ubiquitin, a highly conserved 76-amino acid polypeptide, to proteins that are 
destined for degradation by the proteasome [2].  Ubiquitin can be attached through the carboxy 
group of a glycine residue found in its C-terminus (Gly76) to a specific lysine in the target 
substrate [5].  UPS occurs through successive reactions involving three classes of enzymes: 
ubiquitin–activating (E1), ubiquitin–conjugating (E2), and ubiquitin–ligase (E3) enzymes 
(Figure 1) [8].  The hydrolysis of one ATP molecule drives the formation of a thioester bond 
between a cysteine in the E1’s active site and the carboxy-terminus of ubiquitin [8].  The 
ubiquitin moiety, which is now activated upon interaction with the E1, binds to an active site 
cysteine residue on the E2 enzyme resulting in the formation of a new thioester bond [8, 11].  
The E2 enzyme is involved in conjugating the active ubiquitin to a specific substrate bound to an 
E3 ligase [11].   
Depending upon the different classes of E3 enzymes, the ubiquitin can be conjugated 
directly or indirectly to the E3-bound substrate [11].  The HECT (homologous to the E2-AP 
COOH terminus) ligases utilize an indirect process in which the ubiquitin is transferred from the 
E2 to an active site cysteine residue on the E3 thus creating an ubiquitin-thioester intermediate 
[11].  Following this formation, the ubiquitin is then transferred to the ligase-bound substrate 
[11].  On the contrary, RING-type ligases catalyze the direct transfer of ubiquitin to the target 
substrate thus facilitating as a scaffold protein to bring the substrate and the E2 closer together 
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[7, 11].  In essence, the E3 confers substrate specificity and catalyzes the covalent attachment of 
ubiquitin to the ɛ-amino group of an internal lysine residue in the substrate [8, 12].  The 
conjugation of ubiquitin to the substrate can occur once (monoubiquitination) or multiple times 
thereby creating a polyubiquitin chain [8, 10].  Ubiquitin elongation involves the linkage of the 
C-terminal glycine residue (Gly76) of the new ubiquitin monomer to a specific lysine  
residue - Lys6, Lys11, Lys27, Lys29, Lys33, Lys48, and Lys63 - found in the previously ligated 
ubiquitin [2, 11].  The degradation of the ubiquitin-tagged substrate by the 26S proteasome 
complex is contingent upon the length and the type of the ubiquitin-chain formed [8].  Of the 
components involved in the UPS, the E3 ligases play a pivotal role in determining the fate of the 
targeted protein since these enzymes perform the following tasks: provide the specificity of 
which proteins should be targeted with ubiquitin, determine the length of the ubiquitin chain, and 
decide at which positions the poly-ubiquitin molecules should be linked [8, 11].   
As for the number of identified ubiquitin enzymes, there are two E1s, more than 30 E2s, 
and over 1000 E3s known to exist in eukaryotes [11].  In regards to its E3 classification, Parkin 
is specifically identified as a RING-in-between-RING (RBR) ligase [10].  It has been revealed 
that this group uses both RING and HECT-like mechanisms to perform the ubiquitin transfer 
[12].  Additionally, a key characteristic that distinguishes the RBR ligases from other types of E3 
ligases is the use of an auto-inhibitory mechanism that modulates ubiquitination activity [12].  
The precise mechanism and understanding of Parkin’s role in the ubiquitination of mitochondrial 
substrates has not been well established [2, 3, 7, 8, 10, 12].  Very little is known about RBRs role 
in regulating substrate recognition and more specifically, the interaction of Parkin with its E2 
enzymes is poorly understood [8, 12].  Recent investigations on Parkin’s activation and 
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enzymatic function at mitochondria have revealed preliminary information about its interaction 
with its E2 enzymes [2, 7].  It is believed that the E2 enzymes that interact with Parkin play a 
significant role as direct or indirect regulators of Parkin’s involvement in mitophagy [7].  In 
addition, the appearance of distinct ubiquitin-linkages with specific lysines (Lys48, Lys63, 
Lys27) suggests further support for the involvement of E2 enzymes in Parkin-mediated 
mitophagy [7].  Thus, by identifying new E2 partners of Parkin and other potential substrates and 
clarifying their functions, it is possible to further determine the mechanism of Parkin’s regulation 






Figure 1: Schematic diagram of E3 ubiquitin-protein ligase Parkin indicating the various domains present 
throughout its sequence. 
The ubiquitin-like domain is located in the N-terminus region and is speculated to be involved in 
binding ubiquitin-interacting motifs.  Unique to parkin, the RING0 domain coordinates two zinc 
atoms with a hairpin.  The RING1 domain, which contains an E2 binding site, displays the 
common cross-brace zinc coordination that is typical of other RING domains.  The IBR region is 
involved in maintaining Parkin’s conformational flexibility.  The RING2 domain has a similar 





Figure 2: Schematic overview of the ubiquitination system. 
The ubiquitination of a target protein is performed by three different enzymes: ubiquitin-
activating enzyme (E1), ubiquitin-conjugating enzyme (E2), and ubiquitin-ligating enzyme (E3).  
The activation of ubiquitin is an ATP-dependent process that occurs through the formation of a 
thioester bond with E1.  When the ubiquitin is attached to E2, it can be directly or indirectly 
transferred to the substrate.  The E3 enzyme facilitates bringing the E2-ubiquitin complex closer 





CHAPTER TWO: MATERIALS AND METHODS 
Yeast Two-Hybrid System 
The yeast two-hybrid system is a valuable technique that can be utilized to identify 
interactors of a certain protein of interest [13].  The nature of these interactors can define the 
function of the protein and provide information on the mechanism involved.  Furthermore, this 
method can be used to identify the domains or residues that are involved in the interaction 
between the two proteins [13].  In summary, the “bait” refers to the protein of interest, while the 
potential protein interactors are identified as the “prey”.  The basis behind the yeast two-hybrid 
system is to generate two hybrid proteins: the bait fused to a LexA DNA-binding domain and the 
prey fused to an activation domain [13].  When these two proteins are separated, neither is able 
to initiate transcription of the reporter gene lacZ; however, the interaction between these two 
hybrid proteins activates the transcription of lacZ [13].  The benefit of using this reporter gene is 
that lacZ encodes for the β-galactosidase enzyme which produces an intense blue color to the 
yeast product when the medium contains the substrate X-gal [13].  After performing various tests 
to eliminate false negatives, the presence of blue colonies on the appropriate medium allows for 





Previous Use of Yeast Two-Hybrid System 
In Zervos lab, the yeast two-hybrid screen was previously used successfully to identify 
specific E2 conjugating enzymes of Mulan, an E3 ubiquitin ligase that is embedded in the outer 
mitochondrial membrane [14].  It contains a RING finger domain facing the cytoplasm and an 
additional large domain in the intermembrane space [14].  Though the mechanism of its function 
is currently unknown, Mulan is an important factor in a variety of cellular processes, such as cell 
growth, cell death, and autophagy/mitophagy [14].  The initial yeast two-hybrid screen revealed 
four E2 conjugating enzymes that were capable of forming complexes with Mulan.  After 
determining the E2 partners of Mulan, an additional, modified yeast-two hybrid screen was 
performed to identify possible interactors for each Mulan-E2 heterodimer complex [14].  From 
this screening, several distinct interactors for each Mulan-E2 complex were isolated and 
analyzed, thus revealing critical information regarding Mulan’s involvement in mitophagy [14].  
This study serves as an example of how the identification of protein-protein interactions can 





Polymerase Chain Reaction (PCR) 
The forward and reverse primers, which flank the cDNA sequence of Parkin (coding for 
amino acids 124-465), contain an EcoRI and BamHI restriction site (respectively).   
Forward: 5’-GCGGAATTCCACACTGACAGCAGGAAGGACTC-3’ 
Reverse:  5’-CGCGGATCCCTACACGTCGAACCAGTGGTC-3’ 
In order to amplify the target DNA sequence, a PCR reaction was performed using these primers.  
The reaction mixture contained a total volume of 50 µl and included the following components: 
20 ng of template DNA, 10 nM in 1 µl of each primer, 5 µl of 10X PCR Buffer + Mg2+, 1.5 
units in 1 µl of TAQ Polymerase, 10 µM of dNTPs,  and 40.8 µl of sterile H2O.  This mixture 
was made in duplicate and placed in a thermal cycler to perform the reaction.  The PCR program 
consisted of an initial denaturation step at 95℃ for two minutes and 25 cycles of the following 
steps: denaturation at 95℃ for 30 seconds, annealing at 60℃ (dependent upon primers) for 30 
seconds, and elongation at 72℃ for 70 seconds.  The final step, known as the incubation period 
to ensure that any single-stranded DNA is fully extended without any gaps, lasted for 3 minutes 
at 72℃.  After performing this procedure, the duplicate mixtures were combined and precipitated 





Restrictive Enzyme Digestion 
In preparation for DNA ligation, a restriction enzyme digestion was performed.  The 
reaction mixture of each digestion contained a total volume of 100 µl and was incubated at 37℃ 
for two hours.  Plasmid DNA was first digested with BamHI restriction enzyme using the 
following components: 3 µl of pGilda DNA (2.25 µg/µl), 10 µl of BamHI 10X buffer, 1 µl of 
100X BSA, 1.5 µl of BamHI, and 84.5 µl of sterile H2O.  In a separate reaction, the PCR product 
was initially digested with BamHI.  This reaction mixture contained 25 µl of the PCR product, 
10 µl of 10X BamHI buffer, 1 µl of 100X BSA, 62.5 µl of sterile H2O, and 1.5 µl of BamHI.  
The product from the BamHI digestion was then precipitated in preparation for the second 
restriction enzyme digestion with EcoRI.  The pellet from the precipitation was combined with 
10 µl of 10X EcoRI buffer, 1 µl of 100X BSA, 1.5 µl of EcoRI, and 87.5 µl of sterile H2O.  After 
the PCR product digestion with BamHI, the product was then precipitated, and the pellet was 
combined with 10 µl of 10X EcoRI buffer, 1 µl of 100X BSA, and 87.5 µl of sterile H2O, and 1.5 
µl of EcoRI.  DNA gel electrophoresis was performed to estimate the DNA concentration of 






Following restrictive enzyme digestion, the DNA insert was ready for ligation into 
pGilda.  This specific ligation reaction mixture consisted of the following: 1.5 µl of 10X Ligation 
Buffer, 1.5 µl of 10 mM ATP, 1 µl of DNA ligase, 8 µl of insert, and 4µl of vector.  In general, a 
3:1 ratio of insert DNA to vector is used to determine the appropriate amount.  The reaction 
mixture was first incubated for 5 minutes at room temperature and then transferred to a 70℃ 
water bath for 15 minutes to deactivate DNA ligase.  The final volume of the samples was 
brought up to 50 µl and an additional 500 µl of N-butanol was added in order to precipitate the 
DNA.  After centrifuging the samples for 10 minutes (13,000 RPM) at 4℃, the supernatant was 
discarded, and the sample was dried in a speed vacuum for 10-12 minutes.  The pellet was then 






For bacterial transformation, 4-6 µl of the DNA ligation product was added into a 100 µl 
aliquot of competent bacterial cells (DH5α), mixed gently, and then transferred to an 
electroporation cuvette that was cooled to 4℃.  The cuvette was placed in the Gene Pulser 
(Biorad) to deliver a single exponential decay pulse of 2.5V.  Following the shock, 700 µl of 
room temperature LB medium without any antibiotics was added immediately to the cuvette.  
The mixture was then transferred to a 2 ml microcentrifuge tube and incubated at 37℃ for one 
hour.  Used as the negative control, the plasmid without the insert was also transformed 
following the same protocol.  After the incubation period, different volumes of the mixture (150 
µl and 250 µl) were plated on LB agar plates containing ampicillin (the selectable marker present 
in pGilda) and incubated overnight at 37℃.  The following day, 30 single bacterial colonies were 
picked from the plates, and each colony was grown overnight in 1.5 ml of LB media containing 





Quick Isolation of Plasmid DNA from Bacteria (Miniprep) 
The DNA boiling method (Miniprep) was used to quickly isolate plasmid DNA from the 
bacterial colonies.  The suspensions grown overnight were transferred to 1.5 ml Eppendorf tubes 
and centrifuged for 2 minutes at a speed of 13,000 RPM.  After aspirating the supernatant, the 
pellet was resuspended in 300 µl of a STET/lysozyme mixture (8% Sucrose, 5% 100X Triton, 50 
mM Tris-HCL (pH 8), 50 mM of EDTA, and 600 µl Lysozyme (10 mg/ml)).  The samples were 
briefly vortexed, placed in a boiling water bath for 1 minute, and centrifuged for 10 minutes 
(13,000 RPM).  The pellet, which contained cellular debris, was removed with a toothpick and 
discarded.  In each tube, 200 µl of Isopropanol was added, and the samples were mixed 
thoroughly before centrifugation for 10 minutes (13,000 RPM).  After removing the supernatant, 
each pellet was washed with 200 µl of 70% ice-cold ethanol and centrifuged for an additional 5 
minutes.  Following centrifugation, the ethanol was removed, and the DNA pellet was dried in a 
speed vacuum for 10 minutes.  50 µl of TE was added to each tube to resuspend the DNA.  3 µl 
from each tube was then checked with DNA gel electrophoresis to determine which samples 





To ensure that the insert DNA was properly ligated into pGilda, ten Miniprep samples 
were selected for a double digestion with EcoRI and BamHI.  Each of the reaction mixtures 
contained the following: 2 µl of 10X EcoRI Buffer, 0.2 µl of 10X BSA, 0.3 µl of EcoRI, 0.3 µl 
of BamHI, 4 µl of Miniprep DNA, and 13.2 µl of sterile H2O.  After incubating the mixtures for 
4 hours at 37℃, the samples were checked with DNA gel electrophoresis to analyze which 
samples contained the insert.  The undigested samples of the selected Minipreps were run side-
by-side with the digested samples.  If two bands were present for the digested sample, this 
signified that this specific clone was positive and contained the insert.  Eight of the ten Miniprep 





CHAPTER THREE: RESULTS 
Yeast Two-Hybrid Screening 
For the yeast two-hybrid screening, the EGY48 strain with the LexA-β galactosidase 
reporter construct (PSH 18-34) was used as the host to screen for protein interaction.  The yeast 
was then transformed using 1 µl of the LexA-Parkin124-465 plasmid DNA from the positive 




Glucose plates, and incubated for 2-3 days at 30℃.  A single 




 Glucose media and induced for four hours the 
following day.  To determine whether the target protein was expressed, a Western blot was 
performed using LexA antibodies.  The upper band of the Western blot represents the protein 
expression of LexA-Parkin124-465, which is estimated to be around 57 kDa (Figure 3).   
Before continuing with the screening, a color test was performed to ensure that the bait 
cannot self-activate, and a growth test was conducted to verify that the bait cannot activate the 
endogenous Leu
-
 gene required for growth on selective media.  For the color test, one of the 




 glucose media and the next 
day, a yeast transformation was performed using the pJG4-5 empty vector.  Various volumes 






 Glucose media and incubated for 2-3 days.  Single colonies from the 






Galactose/Raffinose X-Gal agar plate to detect 
the presence of blue colonies (Figure 4).  The results from this test reveal that LexA-Parkin124-465 
+ pJG4-5 (empty) did not turn blue thus signifying that it is not self-activating.  Additionally, the 













Figure 3: Western blot to verify the expression and stability of LexA-Parkin124-465 in yeast. 
Six yeast colonies transfected with LexA- Parkin124-465 and one colony with the pGilda vector 




 galactose media; yeast were lysed and proteins separated by SDS-






Figure 4: Color test to verify lack of self-activation of the LexA-Parkin124-465 bait in yeast. 






Galactose/Raffinose/X-Gal plate.  Blue color developing after overnight incubation indicates 
activation of the reporter β-galactosidase gene.  LexA-Parkin124-465 did not self-activate the 






Figure 5: Growth test to further verify that the LexA-Parkin124-465 bait cannot activate endogenous Leu
-
 gene.   
Different dilutions of yeast transfected with LexA-Parkin124-465 as well as a positive and negative 








Galactose/Raffinose plates.  After 3 days, the growth of yeast 







High Efficiency Yeast Transformation 
To ensure the highest efficiency and yield of transformants to be used in the library 
screening, a high efficiency yeast transformation was performed.  The key difference between a 
high efficiency transformation versus a standard yeast transformation is that the yeast-bait 
culture must be grown to a specific OD600 of 0.9 before being utilized.  A single yeast colony of 
EGY48 pSH18-34 LexA-Parkin124-465, was picked and grown overnight at 30 °C with shaking in 




Glucose drop out medium.  The next day the culture was diluted to 200 ml with the 
same medium and grown to an OD600 nm of 0.924.  Cells were harvested by centrifugation at 
3800 rpm for 5 minutes.  The supernatant was discarded; cells were washed with 20 ml of sterile 
water and centrifuged for an additional 5 minutes.  After another wash cycle, cells were 
resuspended in 20 ml LA (0.1M LiOAc in TE), spun again for 5 minutes.  Lastly cells were 
resuspended in 5ml of LA.  100 μl of competent yeast was aliquoted in 2 Eppendorf tubes and 
the following components were added: 10 μg DNA (HeLa cDNA library in pJG4-5), 100 μg of 
denatured salmon sperm DNA (carrier DNA) and 600 μl of freshly prepared 40% PEG solution.  
The mixtures were resuspended until homogeneous.  The transformation reaction was then 
incubated at 30°C for 30 minutes and then heat shocked at 42°C for 15 minutes.  Following brief 
centrifugation of the samples to form a pellet, the supernatant was aspirated.  The pellet was 







Glucose selective plates and incubated at 30°C for 2-3 days.  In total, ten big 












 Galactose/Raffinose Plates 








 Galactose/Raffinose plates for growth selection, large 








 Galactose/Raffinose plates with the 
use of toothpicks.  Following an incubation period at 30°C for 2-3 days, the colonies from these 






Glucose to be used as a master plate.  From this plate, 













plates for color selection.  A positive interaction between the bait and the prey was denoted with the 














Glucose/X-Gal signified false positives.  Figure 6 depicts the blue colonies on U-H-W-
Galactose/Raffinose/X-Gal; however, not all of these colonies were true positives. 
 After determining the colonies that turned blue only on U-H-W-Galactose/Raffinose/X-Gal, 






Glucose master plate and inoculated into 
W
-
 glucose medium for selection of the pJG4-5 HeLa library plasmid.  The culture was grown 






Figure 6: HeLa cDNA library screening. 







Galactose/Raffinose/X-Gal whereas white colonies indicate that there is no interaction.  











Release of Plasmid from Yeast 
The yeast culture grown in W
- 
Glucose medium was transferred to a screw cap 
microcentrifuge tube and was centrifuged for 1 min at 13000 rpm.  After aspirating the 
supernatant, the formed pellet was resuspended in 200 μl of yeast lysis solution (2% TritonX-
100, 1% SDS, 100mM NaCl, 10mM Tris pH8.0, 1 mM EDTA).  Approximately 0.3 g of glass 
beads (Sigma) was added to assist in the lysis along with 200 μl of Phenol-chloroform-isamyl 
alcohol (25:24:1).  To homogenous the mixture, each culture was vigorously vortexed for 2 
minutes using a Mini-Beadbeater machine.  Following this procedure, the cultures were 
centrifuged for 5 minutes to separate each sample into three distinct, visible layers.  The top layer 
contained the desired DNA; the middle layer contained protein, while the bottom layer contained 
debris.  Without penetrating the middle layer and contaminating the DNA, the top layer was 
extracted from each sample and added to a new microcentrifuge tube for precipitation.   
Bacterial Transformation of DNA Plasmids from the Yeast into KC8 Cells 
 Following precipitation of the extracted DNA plasmids, the samples were transformed 
into bacterial cells (KC8 strain) utilizing the same method as discussed in the previous chapter 
for bacterial transformation.  After electroporation and incubation for an hour, 250 μl of each 
sample was plated on WM9 ampicillin (AMP) plates and incubated overnight at 37℃.  In 
preparation for isolation of the plasmid DNA, a single colony from each plate was grown 





Determination of True Positive Interactors of LexA-Parkin124-465 
The DNA boiling method, as described in the previous chapter, was utilized to isolate the 
plasmid DNA.  The key aspect of the bacterial transformation into KC8 cells and isolation of the 
DNA plasmid via Miniprep is to determine the specific prey plasmid that is interacting with the 
bait.  Whereas yeast can carry multiple types of plasmids, bacteria are more selective in that each 
bacterial cell can only contain a single type plasmid.  Therefore, the bacterial transformation with 
the KC8 cells and the isolation of the plasmid DNA is a crucial step in order to narrow down the 
true positive interactors with the bait and the specificity of the prey plasmid.   
The isolated plasmid DNA was transformed back into the same yeast strain containing 







Glucose.  The colonies that grew from these plates were then streaked onto U-H-W- Glucose/X-
Gal and U-H-W- Galactose/Raffinose/X-Gal for color selection.  This time around, a blue colony 
on U-H-W- Galactose/Raffinose/X-Gal and a corresponding white colony on U-H-W- 





Figure 7: True positive interactors with LexA-Parkin124-465. 
To determine whether the blue colonies from the library screening were true positives, the 
corresponding blue colonies were grown in W
-
 media in preparation for the release of the 
plasmid from the yeast.  The plasmids were then extracted from the yeast, transformed into KC8 
bacterial cells, and plated onto WM9 ampicillin plates.  The plasmid DNA, which was isolated 


























Glucose/X-Gal signified a true positive interaction 





Clean DNA QIAprep Isolation of DNA from Bacteria 
In preparation for sequencing, the plasmids were isolated using the QIAprep Spin 
Miniprep Kit, and the protocol was provided by the manufacture (QIAgen).  Individual bacterial 
colonies were grown in 2 ml of LB media and Ampicillin and incubated overnight at 37°C.  The 
following day, these suspensions were mixed and transferred to microcentrifuge tubes, which 
were then centrifuged (11,000 RPM) for 2 minutes.  The supernatant was aspirated, and the 
pellet was resuspended in 200 μl of Resuspension Buffer P1 containing RNase A (100 μg/ml).  
200 μl of Lysis Buffer P2 was then added and to ensure complete cell lysis, the tubes were then 
gently inverted 5-6 times until the solution appeared homogenous and transparent.  With the 
addition of 300 μl of Neutralization Buffer N3, the lysate was neutralized and adjusted to the 
high-salt binding conditions.  The sample was immediately inverted for an additional 5-6 times 
until a white cloudy precipitate formed.  The suspension was then centrifuged (13,000 RPM) for 
an additional 10 minutes.  Using a pipette, the supernatant was transferred to a QIAprep spin 
column that is resting on top of a 2 ml collection tube.  The column was centrifuged for 1 minute 
at 13,000 RPM and the flow-through was discarded.  The column was washed with 500 μl of PB 
Buffer and centrifuged for an additional 1 minute at 13,000 RPM, and the flow-through was 
discarded.  The column was then washed with 750 μl of PE Buffer and centrifuged for 1 minute 
at 13,000 RPM.  The flow-through was once again discarded, and the column was centrifuges for 
an additional 1 minute to remove the residual wash buffer.  After transferring the QIAprep spin 
column to a clean 1.5 ml microcentrifuge tube, 50 μl of EB buffer (10 mM Tris-HCl, pH 8.5) 
was added, allowed to bind for 1 minute, and the column was centrifuged for 2 minutes at 13,000 
RPM to collect the DNA.    
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Sequence LexA-Parkin124-465 Interactors Accession Number 
1 Homo sapiens bolA family member 1 (BOLA1), 




2 Homo sapiens ATP synthase, H
+
 transporting, 
mitocondrial F1complex, epsilonsubunit (ATP5E), 
mRNA 
NM_006886.3 
3 Homo sapiens mitochondrial ribosomal protein L19 
(MRPL19), mRNA 
NM_014763.3 
4 Homo sapiens complement component 4 binding 
protein, beta (C4BPB), transcription variant 1, 
mRNA 
NM_000716.3 
5 Homo sapiens NHP2 non-histone chromosome 
protein 2-like 1 (S.cerevisiae) (NHP2L1), transcript 
variant X2, mRNA 
XM_006724258.1 
6 Homo sapiens lysyl-tRNA synthetase (KARS), 
transcript variant 1, mRNA 
NM_001130089.1 
   
 




CHAPTER FOUR: DISCUSSION 
 Parkin (also known as PARK2) is a cytosolic E3 ubiquitin ligase that is recruited to 
mitochondria during times of cellular stress and participates in mitophagy [5-7].  Mutations in 
the PARK2 gene have been associated with the development and progression of autosomal 
recessive early-onset Parkinson’s disease (PD) [1, 2, 9].  The complete details of Parkin’s 
mechanism of action and involvement in mitophagy are not fully established.  One of the 
approaches used to investigate the function of a protein is the yeast two-hybrid system.  In this 
case, the function of a protein is defined by its specific interaction with other interactors.  This 
approach has been recently used successfully in our laboratory to characterize the function of yet 
another E3 ubiquitin ligase, Mulan [5, 14].  Parkin has several distinct domains that could be 
involved in protein-protein interactions (Figure 2) suggesting that is has the potential to interact 
with multiple proteins at the same time.  For this project, I have used the yeast two-hybrid 
system to isolate and characterize proteins that could interact with Parkin124-465.  I have excluded 
the 124 amino terminal amino acids from the bait because the focus of the study was to 
determine potential interactors with the RING domains of Parkin.  In addition, it has been 
reported that the amino terminal of Parkin acts as an inhibitor to other protein-protein 
interactions [10].  For the screening, I decided to use a HeLa cDNA library that has previously 
been used successfully in our laboratory.   
 Six positive interactors were identified and characterized (Table 1).  From these six 
interactors, based on what is known, at least one of them has the potential to be a physiological 
partner of the Parkin protein.  This interactor is the Homo sapiens bolA family member 1, 
otherwise known as BolA homolog 1 (BOLA1).  Although this protein has been predominately 
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studied in Escherichia coli, three homologs of the BolA protein family have been identified in 
human and yeast [15].  In E.  coli, the BolA gene is upregulated under cellular stress and is 
involved in the regulation of cell wall proteins; however, its precise mechanism of action has yet 
to be clarified [15].  While sufficient experimental data analyzing the biological function of 
BOLA1 is lacking, it is suggested that this specific homolog has a function in regulating normal 
mitochondrial morphology in aerobic eukaryotes [15].  Furthermore, even though it appears to be 
ubiquitously expressed in humans, it is not overly-expressed in any specific tissues [15].   More 
studies are needed to verify whether this interactor binds to Parkin in mammalian cells and under 
what conditions. 
 Another interesting interactors identified in my screen of Parkin was the lysyl-tRNA 
synthetase which is encoded by the KARS gene [16].  This specific enzyme is responsible for the 
charging of tRNA
Lys
 molecules and is required in both the mitochondria and the cytoplasm in 
order for protein translation to occur [16, 17].  In regards to its clinical application, mutations in 
the KARS gene are implicated in the onset of Charcot-Marie-Tooth (CMT) disease, which is 
characterized by a variety of peripheral nerve disorders, such as a decrease in motor nerve 
conduction velocities, axonal loss, or a decrease in the amplitudes of nerve responses [17].  
Additionally, evidence suggests that KARS mutations in the cytoplasmic enzyme are inherited as 
a recessive trait, and the presence of two mutant alleles can result in the most severe phenotype 
of this neuropathic disorder [16].  It is hypothesized that KARS variants disrupt the 
aminoacylation process through the formation of an active Lysine tRNA synthetase (LysRS) 
tetramer, resulting in the interference of tRNA binding activity [16].  However, the effects of 
impairment and dysfunction in the mitochondrial enzyme of the KARS gene have not been fully 
33 
 
analyzed, and it has yet to be determined whether LysRS has a direct connection to the 
regulation of mitochondrial dynamics [16].   
 Since our bait (Parkin124-465) encompasses multiple protein-protein domains within its 
structure, the use of smaller baits can further elucidate the exact area of Parkin that is involved in 
each interaction.  This could therefore provide information in regards to which proteins interact 
with a specific RING domain and how the interaction affects the function of Parkin.  
Additionally, to investigate whether the protein interactors from this experiment can interact with 
Parkin in mammalian cells, co-immunoprecipitation experiments will be carried out to 
characterize whether these protein complexes form in such cells.  Because Parkin is a cytosolic 
protein that is recruited to the mitochondria during cellular stress, another interesting point to 
investigate would be to determine the cellular location of the protein interaction with Parkin, 
whether it is in mitochondria or in the cytosol.  Furthermore, since Parkin is classified as an E3 
ubiquitin ligase, future experiments will be performed to analyze whether Parkin ubiquitinates 
the interacting proteins in order to gain a better understanding of its mechanism of action in the 
ubiquitin pathway.  From this project, I have shown that the yeast two-hybrid system can be used 
to study protein-protein interaction using Parkin124-465 as the bait.  Future experiments using the 
results from this screening will be carried out to further characterize the function of Parkin and 
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